{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T15:54:18Z","timestamp":1781193258162,"version":"3.54.1"},"reference-count":24,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:00:00Z","timestamp":1719878400000},"content-version":"unspecified","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2024,6,7]]},"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:p>In this article we report the case of a man with congenital liver disease who later developed psychotic illness and was diagnosed with schizophrenia. We illustrate how decompensation in liver function was associated with the exacerbation of psychotic symptoms. We discuss differential diagnostic challenges, and the possible overlapping neuropathology in these two conditions that may converge on glutamate\/N-methyl-D-aspartate dysfunction. This patient\u2019s case underscores the need for further research to elucidate the possible underlying mechanisms linking congenital liver disease and psychosis.<\/jats:p>","DOI":"10.1136\/bcr-2024-259623","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T23:50:19Z","timestamp":1719964219000},"page":"e259623","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Primary versus secondary psychosis in a patient with congenital liver disease"],"prefix":"10.1136","volume":"17","author":[{"given":"Sormeh","family":"Nourbakhsh","sequence":"first","affiliation":[{"name":"Psychiatry, Westchester Medical Center, Valhalla, New York, USA"},{"name":"New York Medical College, Valhalla, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J","family":"Ferrando","sequence":"additional","affiliation":[{"name":"Westchester Medical Center Health Network, Valhalla, New York, USA"},{"name":"New York Medical College School of Medicine, Valhalla, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,7,2]]},"reference":[{"key":"2025082709195752000_17.7.e259623.1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.64.1.19"},{"key":"2025082709195752000_17.7.e259623.2","doi-asserted-by":"publisher","DOI":"10.1016\/bs.apha.2016.01.006"},{"key":"2025082709195752000_17.7.e259623.3","doi-asserted-by":"publisher","DOI":"10.1111\/pcn.12823"},{"key":"2025082709195752000_17.7.e259623.4","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00726-018-2579-6","article-title":"Characterizing amino-acid Biosignatures amongst individuals with schizophrenia: a case\u2013control study","volume":"50","author":"Cao","year":"2018","journal-title":"Amino Acids"},{"key":"2025082709195752000_17.7.e259623.5","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.2174\/138161212799958594","article-title":"Genetic data supporting the NMDA glutamate receptor hypothesis for schizophrenia","volume":"18","year":"2012","journal-title":"CPD"},{"key":"2025082709195752000_17.7.e259623.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.05.042"},{"key":"2025082709195752000_17.7.e259623.7","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1111\/ajt.13639","article-title":"Depression and frailty in patients with end-stage liver disease referred for transplant evaluation","volume":"16","author":"Cron","year":"2016","journal-title":"Am J Transplant"},{"key":"2025082709195752000_17.7.e259623.8","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0163-8343(94)90059-0","article-title":"Hepatic encephalopathy presenting as delirium and mania: the possible role of bilirubin","volume":"16","author":"M\u00fcller","year":"1994","journal-title":"Gen Hosp Psychiatry"},{"key":"2025082709195752000_17.7.e259623.9","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jhep.2022.06.001","article-title":"EASL clinical practice guidelines on the management of hepatic encephalopathy","volume":"77","author":"Montagnese","year":"2022","journal-title":"J Hepatol"},{"key":"2025082709195752000_17.7.e259623.10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.rgmxen.2019.05.001","article-title":"Pathophysiology of hepatic encephalopathy and future treatment options","volume":"84","author":"Gonz\u00e1lez-Regueiro","year":"2019","journal-title":"Revista de Gastroenterolog\u00eda de M\u00e9xico (English Edition)"},{"key":"2025082709195752000_17.7.e259623.11","doi-asserted-by":"publisher","DOI":"10.1007\/BF02815175"},{"key":"2025082709195752000_17.7.e259623.12","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-008-9115-4"},{"key":"2025082709195752000_17.7.e259623.13","doi-asserted-by":"crossref","DOI":"10.1176\/appi.neuropsych.12020044","article-title":"Using Paliperidone as a Monotherapeutic agent on a schizophrenic patient with cirrhosis of the liver","volume":"25","author":"Chou","year":"2013","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"2025082709195752000_17.7.e259623.14","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2009.09081243"},{"key":"2025082709195752000_17.7.e259623.15","doi-asserted-by":"crossref","first-page":"5515","DOI":"10.3748\/wjg.v28.i38.5515","article-title":"Gastrointestinal and liver disease in patients with schizophrenia: A narrative review","volume":"28","author":"Grant","year":"2022","journal-title":"World J Gastroenterol"},{"key":"2025082709195752000_17.7.e259623.16","doi-asserted-by":"publisher","DOI":"10.1037\/0894-4105.12.3.426"},{"key":"2025082709195752000_17.7.e259623.17","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20001"},{"key":"2025082709195752000_17.7.e259623.18","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.47.3.188"},{"key":"2025082709195752000_17.7.e259623.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(00)00111-2"},{"key":"2025082709195752000_17.7.e259623.20","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2012.23"},{"key":"2025082709195752000_17.7.e259623.21","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S2215-0366(14)00081-9","article-title":"Changes in the adolescent brain and the pathophysiology of psychotic disorders","volume":"1","author":"Keshavan","year":"2014","journal-title":"Lancet Psychiatry"},{"key":"2025082709195752000_17.7.e259623.22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/21678707.2018.1409108","article-title":"Inherited Hyperammonemias: a contemporary view on pathogenesis and diagnosis","volume":"6","author":"Maines","year":"2018","journal-title":"Expert Opinion on Orphan Drugs"},{"key":"2025082709195752000_17.7.e259623.23","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jcbfm.9600168"},{"key":"2025082709195752000_17.7.e259623.24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.1995.tb01036.x"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2024-259623","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T16:20:03Z","timestamp":1756311603000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2024-259623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":24,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7,2]]},"published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10.1136\/bcr-2024-259623"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2024-259623","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]}}}